Development of an indirect enzyme-linked immunosorbent assay based on nucleocapsid protein for the detection of swine acute diarrhea syndrome coronavirus antibody.
Yu-Jeong Jang, Nam Phuong Le, Eun-Song Lee, Min-Chae Kim, Tae-Kyung Chang, Jung-Eun Park
{"title":"Development of an indirect enzyme-linked immunosorbent assay based on nucleocapsid protein for the detection of swine acute diarrhea syndrome coronavirus antibody.","authors":"Yu-Jeong Jang, Nam Phuong Le, Eun-Song Lee, Min-Chae Kim, Tae-Kyung Chang, Jung-Eun Park","doi":"10.1186/s12985-025-02834-3","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Swine acute diarrhea syndrome coronavirus (SADS-CoV) is a porcine enteric coronavirus that induces watery diarrhea in pigs, causing substantial economic losses in the swine industry. While the molecular and serological epidemiology of SADS-CoV in China has been extensively studied, comprehensive epidemiological studies assessing its prevalence outside China are lacking.</p><p><strong>Results: </strong>In this study, an indirect enzyme-linked immunosorbent assay based on the SADS-CoV N protein (N-iELISA) was developed to evaluate the seroprevalence of SADS-CoV in Korean pig herds. The optimal conditions for N-iELISA were determined through checkerboard titration of serum samples verified via western blotting. The assay showed sufficient specificity and reproducibility, with a cutoff value of 0.484. A total of 540 field samples collected from pig herds across nine provinces in Korea were subsequently tested using the N-iELISA. The findings revealed an overall seroprevalence of SADS-CoV in Korea of 8.70%.</p><p><strong>Conclusions: </strong>These results indicate that the N-iELISA is a reliable tool for seroepidemiological studies of SADS-CoV and suggest that the seroprevalence of SADS-CoV in the Korean pig population is relatively low.</p>","PeriodicalId":23616,"journal":{"name":"Virology Journal","volume":"22 1","pages":"201"},"PeriodicalIF":4.0000,"publicationDate":"2025-06-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12181908/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Virology Journal","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s12985-025-02834-3","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"VIROLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Swine acute diarrhea syndrome coronavirus (SADS-CoV) is a porcine enteric coronavirus that induces watery diarrhea in pigs, causing substantial economic losses in the swine industry. While the molecular and serological epidemiology of SADS-CoV in China has been extensively studied, comprehensive epidemiological studies assessing its prevalence outside China are lacking.
Results: In this study, an indirect enzyme-linked immunosorbent assay based on the SADS-CoV N protein (N-iELISA) was developed to evaluate the seroprevalence of SADS-CoV in Korean pig herds. The optimal conditions for N-iELISA were determined through checkerboard titration of serum samples verified via western blotting. The assay showed sufficient specificity and reproducibility, with a cutoff value of 0.484. A total of 540 field samples collected from pig herds across nine provinces in Korea were subsequently tested using the N-iELISA. The findings revealed an overall seroprevalence of SADS-CoV in Korea of 8.70%.
Conclusions: These results indicate that the N-iELISA is a reliable tool for seroepidemiological studies of SADS-CoV and suggest that the seroprevalence of SADS-CoV in the Korean pig population is relatively low.
期刊介绍:
Virology Journal is an open access, peer reviewed journal that considers articles on all aspects of virology, including research on the viruses of animals, plants and microbes. The journal welcomes basic research as well as pre-clinical and clinical studies of novel diagnostic tools, vaccines and anti-viral therapies.
The Editorial policy of Virology Journal is to publish all research which is assessed by peer reviewers to be a coherent and sound addition to the scientific literature, and puts less emphasis on interest levels or perceived impact.